A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: A southwest oncology group trial

Gynecologic Oncology

Volumn 37, Issue 3, 1990, Pages 354-358

  Weiss, Geoffrey R ^a   Green, Stephanie ^b   Hannigan, Edward V ^c   Boutselis, John G ^d   Surwit, Earl A ^e   Wallace, Darryl L ^f   Alberts, David S ^e  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f Midwest CCOP ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CISPLATIN; FLUOROURACIL;

AGE; ANEMIA; ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; METASTASIS; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ALLOPURINOL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; CARCINOMA; CERVIX NEOPLASMS; CISPLATIN; DRUG EVALUATION; FEMALE; FLUOROURACIL; GASTROINTESTINAL DISEASES; HUMAN; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL;

EID: 0025340840     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/0090-8258(90)90366-S     Document Type: Article

References (16)

1. Cancer statistics, 1989
2. Chemotherapy of cervical carcinoma
3. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: A Southwest Oncology Group study
4. Improved complete response rate and survival in advanced head and neck cancer after three course induction therapy with 120-hour 5-FU infusion and cisplatin
5. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
6. Cisplatin and 5-FU infusion chemotherapy in advanced recurrent cancer of the head and neck: An Eastern Cooperative Oncology Group pilot study
7. A phase II study of cis-diaminedichloro-platinum and 5-fluorouracil in advanced upper aero-digestive neoplasms
8. Twenty-four hour infusion cisplatin and 5-day infusion 5-fluorouracil in recurrent head and neck squamous cancer
9. Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer
10. Lack of inhibition by oxipurinol of 5-fluorouracil toxicity against human tumor cells lines
11. Modulation of 5-fluorouracil toxicity by allopurinol in man
12. Phosphoribosyl transferase in colon tumor and normal mucosa as an aid in adjuvant chemotherapy with 5-fluorouracil (NSC-19893)
13. Modulation of fluorouracil toxicity
14. Phase III trial of high-dose 5-FU infusion with allopurinol in metastatic colorectal cancer
15. High-dose allopurinol modulation of 5-FU toxicity: Phase I trial of an outpatient dose schedule
16. Failure of allopurinol to provide clinically significant protection against the hematologic toxicity of a bolus 5-FU schedule